Please login to the form below

Not currently logged in
Email:
Password:

Just::

This page shows the latest Just:: news and features for those working in and with pharma, biotech and healthcare.

Merck to acquire Pandion Therapeutics for $1.85bn

Merck to acquire Pandion Therapeutics for $1.85bn

In just a few years, we have taken that mission from idea to clinical proof of mechanism with PT101, our lead IL-2 mutein,” said Rahul Kakkar, chief executive officer, Pandion.

Latest news

  • Don't hesitate, vaccinate! Don't hesitate, vaccinate!

    So, this is more than just anti-vax, it suggests a more mainstream hesitancy. ... Codes and regulatory aspects don’t disappear just because we are trying to do something good.

  • HCA releases new PR media guide HCA releases new PR media guide

    It is frightening to hear the consistency in how journalists want to be approached and then the degree to which this is just not happening appropriately. ... This guide is a great resource for those just starting in PR, but it also provides a useful

  • Pandemics for dummies Pandemics for dummies

    After all, without the trained personnel they are just beds. It’s the people managing the beds that make them critical care beds.

  • Pfizer's basic instincts Pfizer's basic instincts

    Signalling strategy. On the surface, both the Pfizer logo change and the Viatris name change are just the sort of superficial fluff that generally doesn’t interest me.

  • UK hits ‘significant milestone’ as 15 million people receive their first COVID-19 vaccine dose UK hits ‘significant milestone’ as 15 million people receive their first COVID-19 vaccine dose

    Hitting this milestone just ten weeks after the NHS made history by delivering the first COVID-19 vaccination outside of a clinical trial is a remarkable shared achievement,” said Sir Simon

More from news
Approximately 6 fully matching, plus 3,396 partially matching documents found.

Latest Intelligence

  • Reaching patients and HCPs during the pandemic Reaching patients and HCPs during the pandemic

    Digital-first HCPs. With HCPs going digital, an entirely new playing field has opened up for pharma companies to not just promote, but actually enable outcomes. ... Digital- first HCPs will not just communicate digitally with MSLs, but increasingly also

  • Back to the future Back to the future

    In 2016, I did just that in a critically acclaimed book and a series of four PME articles. ... This is much more than a mere analogy; Generalised Darwinism is a body of science that applies just as well to business as it does to biology.

  • Working in true partnership in a time of change Working in true partnership in a time of change

    Therefore, understanding current trials and published papers is not just for the medical team; everyone working in healthcare should know their products’ ecosystem, including competitor developments that are breaking new ground.

  • Rare genetic diseases – what’s in store for 2021? Rare genetic diseases – what’s in store for 2021?

    If gene therapy becomes an option for more diseases, particularly those that are rare and currently untreatable, then those diseases could be treated with just one single administration, changing lives and ... It has taken 30 years for gene therapy to

  • The remote working revolution The remote working revolution

    It is a nice leveller because we are all just people trying to do the best we can in difficult circumstances.”.

More from intelligence
Approximately 2 fully matching, plus 676 partially matching documents found.

Latest appointments

More from appointments
Approximately 3 fully matching, plus 66 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 665 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

4 ways to recruit Alzheimer’s disease patients for your clinical trial
What key things do you need to remember to reach patients living with Alzheimer’s disease?...
competitive intelligence
Integrating competitive intelligence into business development, licensing and M&A strategy
The advantages of partnering with a competitive intelligence or knowledge management team...
reaching HCPs during pandemic
Reaching patients and HCPs during the pandemic
COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...

Infographics